Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.
about
Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic NephropathyThe podocyte power-plant disaster and its contribution to glomerulopathy.Loss of Krüppel-like factor 6 cripples podocyte mitochondrial function.Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.What we need to know about the effect of lithium on the kidney.The Emerging Role of Mitochondrial Targeting in Kidney Disease.The prognostic value of oxidative stress and inflammation in Chinese hemodialysis patients.Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.Mitochondria Damage and Kidney Disease.
P2860
Q28083205-8A906800-CAE9-478C-94E7-82E0E5538355Q34699773-B0C6BC0B-7328-4A7F-98F6-E35AA1D79593Q35183931-724D3421-BD34-427E-8612-F56DD93DF01EQ36217903-82FAB121-4307-4F68-845F-04AD708E973DQ36545412-51467291-16FD-40D2-8C22-5652AFACE2EAQ36803722-6249E68F-5A8B-465C-880B-FA28D943CA9CQ38819531-E73EB757-F841-4F15-9A14-0A5635066947Q39252634-D3771A4F-39E2-437F-87E2-9731CFF8DD0AQ40526621-A4ACB2C5-8401-4915-920D-54698168FFCDQ42141815-EA7FB3E9-8254-467B-B9FC-85B6FB1CEE2BQ48026176-E8E60D3E-CBD9-4609-A8E8-47DFD13EB43B
P2860
Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacological targeting of G ...... drial permeability transition.
@ast
Pharmacological targeting of G ...... drial permeability transition.
@en
Pharmacological targeting of G ...... drial permeability transition.
@nl
type
label
Pharmacological targeting of G ...... drial permeability transition.
@ast
Pharmacological targeting of G ...... drial permeability transition.
@en
Pharmacological targeting of G ...... drial permeability transition.
@nl
prefLabel
Pharmacological targeting of G ...... drial permeability transition.
@ast
Pharmacological targeting of G ...... drial permeability transition.
@en
Pharmacological targeting of G ...... drial permeability transition.
@nl
P2093
P2860
P356
P1476
Pharmacological targeting of G ...... drial permeability transition.
@en
P2093
P2860
P304
P356
10.1111/BPH.12952
P407
P50
P577
2014-12-15T00:00:00Z